Photodynamic therapy using talaporfin sodium and semiconductor laser induces dose and time dependent cytocidal effect

Megumi Ichikawa1, Jiro Akimoto2, Srivalleesha Mallidi1

  • 1Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

Insights

Photodynamic therapy (PDT) using talaporfin sodium (NPe6) effectively reduced glioblastoma stem cell viability and induced cell death. Enhancing oxygen levels may improve NPe6-PDT efficacy against treatment-resistant glioma stem cells.

Area of Science:

  • Oncology
  • Biomedical Engineering
  • Photochemistry

Background:

  • Glioblastoma (GBM) poses a significant therapeutic challenge due to the treatment resistance of glioma stem cells (GSCs).
  • Photodynamic therapy (PDT) is an emerging treatment modality with potential against resistant cancer cells.
  • Talaporfin sodium (NPe6) is a second-generation photosensitizer used in PDT.

Purpose of the Study:

  • To evaluate the efficacy of NPe6-based PDT against patient-derived GSCs.
  • To investigate the mechanisms of cell death induced by NPe6-PDT in GSCs.
  • To explore potential strategies for enhancing NPe6-PDT effectiveness.

Main Methods:

  • Utilized a patient-derived GSC line (MGG8) from human glioblastoma.
  • Administered NPe6 followed by semiconductor laser irradiation.
  • Assessed mitochondrial metabolic activity, apoptosis, necrosis, and reactive oxygen species (ROS) levels.

Main Results:

  • NPe6-PDT demonstrated dose- and fluence-dependent suppression of mitochondrial activity in MGG8 cells.
  • Induced both apoptosis and necrosis in a time-dependent manner.
  • Increased secondary ROS levels, indicating sustained oxidative stress.

Conclusions:

  • NPe6-PDT is effective against patient-derived GSCs under normoxic conditions.
  • Hypoxic microenvironments may limit PDT efficacy by reducing oxidative damage.
  • Strategies to improve tissue oxygenation could enhance NPe6-PDT therapeutic outcomes for glioblastoma.

Related Concept Videos